Pfizer is going to make headlines again this week with a brand new drug.
The drug, called Zyrtec, is the first to have been approved by the Food and Drug Administration (FDA).
Zyrtec is a new type of arthritis drug that has been developed by Pfizer, which has been using it to treat arthritis since 2003.
Zyrtos is based on a different molecule, known as P-acetylcysteine, that is not found in traditional medicines and is thought to be helpful in treating the arthritis pain.
The new drug has been approved to treat a wide range of conditions and is available in a range of forms including oral and injectable.
The drug will be available for patients to take either in tablet or liquid form, and the drug will have a maximum effective dose of 6 mg/day.
Pfizer says the drug should be effective within three months of treatment, but it will be up to patients to decide whether or not they want to take the drug.
P-acetylcystine is an enzyme that converts acetyl-CoA to acetylcholine, which helps to speed the breakdown of proteins and carbohydrates.
The new drug also has a wide variety of other uses, including treating other types of infections, cancer and heart disease.
Pfizer says that its drug will work by slowing the breakdown and release of proteins that make up the proteins in our body.
The enzyme has been used in medicine for decades, but Pfizer said the new drug will improve the efficiency of its work, helping to improve the quality of life for people with arthritis and other chronic diseases.
Pfeil, the company’s chief scientific officer, said the drug was created using a “brilliant approach to synthesis.”
The drug is the latest of Pfizer’s recent moves to expand its manufacturing in the United States.
Last year, Pfizer announced plans to invest $6 billion to create a $50 billion factory in Indiana and hire 400 new workers in the state.